HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ali Calderon-Aparicio Selected Research

Ali Calderon-Aparicio Research Topics

Disease

6Neoplasms (Cancer)
12/2021 - 10/2015
2Melanoma (Melanoma, Malignant)
01/2019 - 10/2015
1Prostatic Neoplasms (Prostate Cancer)
12/2021
1Neoplasm Metastasis (Metastasis)
12/2021
1Colonic Neoplasms (Colon Cancer)
12/2020
1Esophageal Neoplasms (Esophageal Cancer)
11/2020
1Colorectal Neoplasms (Colorectal Cancer)
01/2019
1Breast Neoplasms (Breast Cancer)
10/2015

Drug/Important Bio-Agent (IBA)

2Transcription Factors (Transcription Factor)IBA
02/2021 - 11/2020
2tetrathiomolybdate (ammonium tetrathiomolybdate)IBA
01/2019 - 10/2015
2Disulfiram (Antabuse)FDA Link
01/2019 - 10/2015
2Chelating AgentsIBA
01/2019 - 10/2015
2CopperIBA
01/2019 - 10/2015
1ProteomeIBA
12/2021
1Messenger RNA (mRNA)IBA
12/2021
1Biomarkers (Surrogate Marker)IBA
02/2021
1ERRalpha Estrogen-Related ReceptorIBA
12/2020
1SOXB1 Transcription FactorsIBA
11/2020
1Proteins (Proteins, Gene)FDA Link
11/2020
1neocuproineIBA
01/2019
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019
1EnzymesIBA
01/2019
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2019
1U 0126 (UO 126)IBA
01/2019
11,10-phenanthrolineIBA
01/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2015

Therapy/Procedure

3Therapeutics
12/2021 - 01/2019
1Radiotherapy
02/2021
1Drug Therapy (Chemotherapy)
02/2021